Cellugen Biotech Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2008.

2008 New Delhi, Delhi, India Under Cirp

Last Updated: July 25, 2025

About Cellugen Biotech Private Limited

Cellugen Biotech Private Limited, a under cirp private limited company, was established on 18 August 2008 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the professional, scientific and technical sector, it holds CIN: U85110DL2008PTC182124. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.

Formerly known as Unistem Biosciences Private Limited, Beike Biotech India Private Limited. It upholds a compliant status. Its leadership includes Lalit Jaiswal (Director), Kangan Jaiswal (Director). Past directors included Kanishk Jaiswal, Umesh Arunbhai Yagnik, Kangan Jaiswal. It holds ₹5.67 Cr open charges and no settled loans. Its latest AGM occurred on 19 September 2019, with the balance sheet filed on 31 March 2019. It is based at Innov8 Coworking, Salcon Rasvilas, Lgf, Next To Select City Walk, Saket District Centre, Saket District, Sector 6, Pushp Vihar, New Delhi- 110017., New Delhi, Delhi, 110017.

Company Details

CIN/LLPIN
U85110DL2008PTC182124
Registration Number
182124
Incorporation Date
18 August 2008
Authorized Capital
₹1.00 Cr
Paid-Up Capital
₹1.00 Cr
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Under Cirp

Key Metrics

Authorised Capital ₹ 1.00 Cr as on 25-07-2025
Paid Up Capital ₹ 1.00 Cr as on 25-07-2025
Company Age 17 Year, 6 Months
Last Filing with ROC 31 Mar 2019
Open Charges ₹ 5.67 Cr as on 25-07-2025
Revenue Growth **** 3.56% (FY 2019)
Profit Growth **** -4.34% (FY 2019)
Ebitda **** 6886.89% (FY 2019)
Net Worth 1.26% (FY 2019)
Total Assets **** 15.81% (FY 2019)

Comprehensive Company Insights

Explore comprehensive insights into Cellugen Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Cellugen Biotech Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Lalit Jaiswal	Director	18 Aug 2008	Current
Kangan Jaiswal	Director	25 Mar 2016	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	07 Apr 2022	Past
Pramod Abcsdd	Director	05 Jan 2022	Past
Pramod Abcsdd	Additional Director	30 Sep 2016	Past
Pramod Abcsdd	Director	07 Apr 2022	Past
Pramod Abcsdd	Director	02 Apr 2019	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cellugen Biotech.

Cellugen Biotech Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 3.56% increase. The company also saw a slight decrease in profitability, with a 4.34% decrease in profit. The company's net worth moved up by a moderate rise of 1.26%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

3.56%

*******

Revenue from Operations

*******

10.37%

*******

Total Assets

*******

15.81%

*******

Profit or Loss

*******

-4.34%

*******

Net Worth

*******

1.26%

*******

EBITDA

*******

6886.89%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cellugen Biotech?

In 2019, Cellugen Biotech had a promoter holding of 83.00% and a public holding of 17.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹56,652,941.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Others : 5.67 Cr

Latest Charge Details

Date	Lender	Amount	Status
27 Oct 2020	Others	₹6.65 M	Open
25 Oct 2018	Others	₹5.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Cellugen Biotech?

Unlock and access historical data on people associated with Cellugen Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Cellugen Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cellugen Biotech's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cellugen Biotech

Recent Activity within the Organization

Charges

Progress on A charge with Others amounted to Rs. 0.67 Cr with Charge ID 100384919 was registered on 27 Oct 2020. was documented.
27 Oct 2020
Annual General Meeting

The activity Cellugen Biotech Private Limited last Annual general meeting of members was held on 19 Sep 2019 as per latest MCA records. was completed.
19 Sep 2019
Balance Sheet

Progress on Cellugen Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Delhi. was documented.
31 Mar 2019
Charges

Progress on A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100213634 was registered on 25 Oct 2018. was documented.
25 Oct 2018
Director Appointment

Progress on Kangan Jaiswal was appointed as a Director was appointed as a Director on 25 Mar 2016 & has been associated with this company since 9 years 11 months . was documented.
25 Mar 2016
Director Appointment

Progress on Lalit Jaiswal was appointed as a Director was appointed as a Director on 18 Aug 2008 & has been associated with this company since 17 years 6 months . was documented.
18 Aug 2008

Explore recent activity and updates - View Recent Activity